A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT05891639
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups. This study will investigate the safety and efficacy of bipolar disorder treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future bipolar disorder study.

Key Dates

Start date
Jun 30, 2024
Status verified
May 2023
Primary completion
Jun 30, 2025
Completion
Jun 30, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Rate of bipolar disorder patients who decide to enroll in a clinical research. [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107
Michael B Gill
https://www.withpower.com/[email protected]
415-900-4227

Find similar trials in San Francisco, CA

By condition
Bipolar disorder
By specialty
PsychiatryMental healthBehavioral health
By research site
Power Life Sciences· San Francisco, CA

Related Studies